Publications

5808 Results

Induction chemoradiation plus surgical resection is feasible and highly effective treatment for pancoast tumors: initial results of SWOG 9416 (Intergroup 0160) trial

Authors
MJ Kraut;VW Rusch;JJ Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 19:487a(#1906)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-9416

Phase III randomized trial of bolus 5-FU/leucovorin/levamisole versus 5-FU continuous infusion/levamisole as adjuvant therapy for high risk colon cancer (SWOG 9415/INT-0153)

Authors
E Poplin;J Benedetti;N Estes;D Haller;R Mayer;R Goldberg;J Macdonald
Journal / Conference
Proc of the American Society of Clinical Oncology 19:240a(#931)
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9415 (INT-0153) (CALGB-9498) (ECOG-S9415) (NCCTG-S9415)

Neoadjuvant doxorubicin, cyclophosphamide and G-CSF (AC+G) for locally advanced breast cancer (LABC), a Southwest Oncology Group phase II study

Authors
GK Ellis;SJ Green;RB Livingston;GT Budd;SE Rivkin;JK Giguere;DR Gandara;GR Weiss;S Martino
Journal / Conference
Proc of the American Society of Clinical Oncology 19:85a(#326)
Year
2000
Research Committee(s)
Breast
Study Number(s)
S9625

African American ethnic background is an independent and negative predictor of survival in metastatic prostate cancer

Authors
I Thompson;A Tolcher;ED Crawford;M Eisenberger;C Tangen;E Fisher
Journal / Conference
Journal of Urology 163(4):56Suppl(#242)
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Cytoreduction nephrectomy in metastatic renal cancer: the results of Southwest Oncology Group trial 8949

Authors
RC Flanigan;BA Blumenstein;S Salmon;SI Bearman;V Roy;SP Balcerzak;PC McGrath;JR Caton;B Barlogie;ED Crawford
Journal / Conference
Journal of Urology 163(4)Suppl:154
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8949

Results of CALGB 9480, a phase III trial of 3 different doses of suramin for the treatment of hormone refractory prostate cancer (HRPC).

Authors
S Halabi;EJ Small;RH Ansari;G Wilding;DP Petrylak;DI Palchak;E Marshall;RP Rago;V Hars;NJ Vogelzang
Journal / Conference
Proc of the American Society of Clinical Oncology 19:328a(#1291)
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9452 (INT-0159) (CALGB 9480)

Altretamin (Hexalen) consolidation for patients with stage III epithelial ovarian cancer in clinical complete remission: a Southwest Oncology Group trial (S9326)

Authors
DS Alberts;ML Rothenberg;PY Liu;SA Weiner;V Hunter;A Tiersten;PC Kohler;EV Hannigan;S Wilczynski
Journal / Conference
Proc of the American Society of Clinical Oncology 19:384a(#1520)
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9326

Design of the selenium and vitamin E chemoprevention trial (SELECT)

Authors
PJ Goodman;S Lippman;E Klein;A Ryan;J Crowley;M LeBlanc;CA Coltman, Jr
Journal / Conference
Proc of the Society for Clinical Trials :#11
Year
2000
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

Adjuvant therapy with an allogeneic tumor vaccine in T3N0M0 melanoma (SWOG-9035)

Authors
VK Sondak;PY Liu;RJ Tuthill;RA Kempf;JM Unger;JA Sosman;JA Thompson;GR Weiss;BG Redman;LE Flaherty
Journal / Conference
Proc of the Melanoma at the Millennium :79
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9035

Prognostic value of serum PSA in patients with newly diagnosed metastatic prostate cancer

Authors
D Crawford;I Thompson;A Tolcher
Journal / Conference
Journal of Urology 163(4)Suppl:259(#1149)
Year
2000
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)